330
Views
4
CrossRef citations to date
0
Altmetric
Review

Hemophilic arthropathy: a teaching approach devoted to hemophilia treaters in under-development countries

ORCID Icon
Pages 887-896 | Received 03 Aug 2021, Accepted 02 Sep 2021, Published online: 08 Sep 2021

References

  • Rodriguez-Merchan EC. The role of orthopaedic surgery in haemophilia: current rationale, indications and results. EFORT Open Rev. 2019;4(5):165–173.
  • Kempton CL. Prophylaxis in hemophilia: how much is enough? Blood. 1709-11;2021(137).
  • Manco-Johnson MJ, Abshire TC, Shapiro AD, et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med. 2007;357(6):535–544.
  • Shapiro AD. Concizumab: a novel anti-TFPI therapeutic for hemophilia. Blood Adv. 2021;5(1):279.
  • Rodriguez-Merchan EC, Valentino LA. Emicizumab: review of the literature and critical appraisal. Haemophilia. 2019;25(1):11–20.
  • Makris M, Hermans C. Making treatment decisions in hemophilia based on available safety data. J Thromb Haemost. 2021;19(4):1138–1139.
  • Young G. Management of children with hemophilia A: how emicizumab has changed the landscape. J Thromb Haemost. 2021;19(7):548–556.
  • Jimenez-Yuste V, Auerswald G, Benson G, et al. Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors. Haemophilia. 2021;27(3):340–350.
  • Rodriguez-Merchan EC, Jimenez-Yuste V, Aznar JA, et al. Joint protection in haemophilia. Haemophilia. 2011;17(Suppl 2):1–23.
  • Rodriguez-Merchan EC. Articular bleeding in hemophilia. Cardiovasc Hematol Disord Drug Targets. 2016;16(1):21–24.
  • Merchan ECR, De Orbe A, Gago J. Ultrasound in the diagnosis of the early stages of hemophilic arthropathy of the knee. Acta Orthop Belg. 1992;58:122–125.
  • De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, et al. The value of HEAD-US system in detecting subclinical abnormalities in joints of patients with hemophilia. Expert Rev Hematol. 2018;11(3):253–261.
  • De la Corte-Rodriguez H, Rodriguez-Merchan EC. The role of physical medicine and rehabilitation in haemophiliac patients. Blood Coagul Fibrinolysis. 2013;24(1):1–9.
  • De la Corte-Rodriguez H, Rodriguez-Merchan EC. The current role of orthoses in treating haemophilic arthropathy. Haemophilia. 2015;21(6):723–730.
  • Rodriguez-Merchan EC, Liddle AD. Pathogenesis and treatment options for hemophilic synovitis. Expert Opin Orphan Drugs. 2017;5(2):173–179.
  • De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, et al. Accelerating recovery from acute hemarthrosis in patients with hemophilia: the role of joint aspiration. Blood Coagul Fibrinolysis. 2019;30(3):111–119.
  • Ingram GI, Mathews JA, Bennett AE. Controlled trial of joint aspiration in acute haemophilic haemarthrosis. Ann Rheum Dis. 1972;31(5):423.
  • Siqueira TC, Dominski FH, Andrade A. Effects of exercise in people with haemophilia: an umbrella review of systematic reviews and meta-analyses. Haemophilia. 2019;25(6):928–937.
  • Wagner B, Seuser A, Krüger S, et al. Establishing an online physical exercise program for people with hemophilia. Wien Klin Wochenschr. 2019;131(21–22):165–173.
  • Rodriguez-Merchan EC, De la Corte-Rodriguez H, Jimenez-Yuste V. Radiosynovectomy in haemophilia: long-term results of 500 procedures performed in a 38-year period. Thromb Res. 2014;134(5):985–990.
  • Storti E, Traldi A, Tosatti E, et al. Synovectomy for haemophilic haemarthrosis. Lancet. 1968;11(7567):572.
  • Journeycake JM, Miller KL, Anderson AM, et al. Arthroscopic synovectomy in children and adolescents with hemophilia. J Pediatr Hematol Oncol. 2003;25(9):1–9.
  • Lim MY, Cheng D, Aschman D, et al. on behalf of the ATHN3 working group. Radionuclide synovectomy in patients with bleeding disorders: a review of malignancy and myeloproliferative neoplasms from the ATHNdataset. Haemophilia. 2017;23(2):e133–e169.
  • Rodriguez-Merchan EC, Valentino LA. Safety of radiation exposure after radiosynovectomy in paediatric patients with haemophilia. Haemophilia. 2015;21(4):411–418.
  • Rodriguez-Merchan EC. Radiosynovectomy in haemophilia. Blood Rev. 2019;35:1–6.
  • Kachooei AR, Heidari A, Divband G, et al. Rhenium-188 radiosynovectomy for chronic haemophilic synovitis: evaluation of its safety and efficacy in haemophilic patients. Haemophilia. 2020;26(1):142–150.
  • Ebrahimpour A, Ebrahiminasab M, Kaseb M, et al. Chromic phosphate-32 colloid radiosynovectomy for the treatment of haemophilic synovitis: a long-term follow-up study. Haemophilia. 2020;26(1):136–141.
  • Sunny SS, Hephzibah J, Shanthly N, et al. Yttrium-90 synovectomy in hemophilic arthropathy: an institutional experience for 15 years. Indian J Nucl Med. 2020;35:143–146.
  • Tena-Sanabria ME, Rojas-Sato YF, Castañeda-Resendiz JC, et al. Treatment with radiosynoviorthesis in hemophilic patients with and without inhibitor. BMC Pediatr. 2020;20(1):173.
  • Grmek M, Milcinski M, Fettich J, et al. radiation exposure of hemophiliacs after radiosynoviorthesis with 186 re colloid. Cancer Biother Radiopharm. 2007;22(3):558–566.
  • Gratz S, Gobel D, Behr TM, et al. Correlation between radiation dose, synovial thickness, and efficacy of radiosynoviorthesis. J Rheumatol. 1999;26:1242.
  • Hänscheid H, Lassmann M, Pinkert J, et al. Radiation exposure of patients after radiosynoviorthesis. Eur J Nucl Med Mol Imag. 2005;32(Suppl. 1):120.
  • Buccheri E, Avola M, Vitale N, et al. Haemophilic arthropathy: a narrative review on the use of intra-articular drugs for arthritis. Haemophilia. 2019;25(6):919–927.
  • Li TY, Wu YT, Chen LC, et al. An exploratory comparison of single intra-articular injection of platelet-rich plasma vs hyaluronic acid in treatment of haemophilic arthropathy of the knee. Haemophilia. 2019;25(3):484–492.
  • Carulli C, Rizzo AR, Innocenti M, et al. Viscosupplementation in symptomatic haemophilic arthropathy of the knee and ankle: experience with a high molecular weight hyaluronic acid. Haemophilia. 2020;26(4):e198–e200.
  • Liou IH, Lu LY, Lin KY, et al. Combined intra-articular injections of hyaluronic acid and platelet-rich plasma for the treatment of haemophilic arthropathy: a case series study. Haemophilia. 2021;27(2):e291–e294.
  • De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, et al. Hindfoot malalignment in adults with haemophilic ankle arthropathy: the importance of early detection and orthotic treatment. Haemophilia. 2019;25(3):500–508.
  • Pasta G, Forsyth A, Merchan CR, et al. Orthopaedic management of haemophilia arthropathy of the ankle. Haemophilia. 2008;14(Suppl 3):170–176.
  • Domper-Arnal MJ, Hijos-Mallada G, Lanas A. Gastrointestinal and cardiovascular adverse events associated with NSAIDs. Expert Opin Drug Saf. 2021 Aug;18:1–12. Online ahead of print.
  • Rodriguez-Merchan EC. Musculo-skeletal manifestations of haemophilia. Blood Rev. 2016;30(5):401–409.
  • Rodriguez-Merchan EC, De la Corte-Rodriguez H. Complications of hemophilia in the elbow: current management. Expert Rev Hematol. 2020;13(9):991–1001.
  • Dale TM, Saucedo JM, Rodriguez-Merchan EC. Hemophilic arthropathy of the elbow: prophylaxis, imaging, and the role of invasive management. J Shoulder Elbow Surg. 2015;24(10):1669–1678.
  • Dale TM, Saucedo JM, Rodriguez-Merchan EC. Rodriguez.Merchan EC. Total elbow arthroplasty in haemophilia. Haemophilia. 2018;24(4):548–556.
  • Ernstbrunner L, Hingsammer A, Imam MA, et al. Long-term results of total elbow arthroplasty in patients with hemophilia. J Shoulder Elbow Surg. 2018;27(1):126–132.
  • Yoo MC, Jeong BO, Ahn J. Anterior osteophyte resection of the ankle joint to increase range of motion in haemophilic ankle arthropathy. Haemophilia. 2019;25(3):e159–e164.
  • Rodriguez-Merchan EC. Total ankle replacement or ankle fusion in painful advanced hemophilic arthropathy of the ankle. Expert Rev Hematol. 2015;8(6):727–731.
  • Brkljac M, Shah S, Hay C, et al. Hindfoot fusion in haemophilic arthropathy: 6-year mean follow-up of 41 procedures performed in 28 adult patients. Haemophilia. 2016;22(2):e87–e98.
  • Rodriguez-Merchan EC. Management of hemophilic arthropathy of the ankle. Cardiovasc Hematol Disord Drug Targets. 2017;17(2):142–150.
  • Eckers F, Bauer DE, Hingsammer A, et al. Mid- to long-term results of total ankle replacement in patients with haemophilic arthropathy: a 10-year follow-up. Haemophilia. 2018;24(2):307–315.
  • Sackstein P, Cooper P, Kessler C. The role of total ankle replacement in patients with haemophilia and end-stage ankle arthropathy: a review. Haemophilia. 2021;27(2):184–191.
  • Rodriguez-Merchan EC, Valentino LA. Orthopedic disorders of the knee in hemophilia: a current concept review. World J Orthop. 2016;7(6):417–422.
  • Liddle AD, Rodriguez-Merchan EC. Evidence-based management of the knee in hemophilia. JBJS Rev. 2017;5(8):e12.
  • Rodriguez-Merchan EC, Gomez-Cardero P. Arthroscopic knee debridement can delay total knee replacement in painful moderate haemophilic arthropathy of the knee in adult patients. Blood Coagul Fibrinolysis. 2016;27(6):484–492.
  • Rodriguez-Merchan EC. Total knee arthroplasty in hemophilic arthropathy. Am J Orthop (Belle Mead NJ). 2015;44:E503–E507.
  • Santos Silva M, Rodrigues-Pinto R, Rodrigues C, et al. Costa E Castro J. Long-term results of total knee arthroplasty in hemophilic arthropathy. J Orthop Surg. 2019;27:2309499019834337. Hong Kong
  • Bae JK, Kim KI, Lee SH, et al. Mid-to long-term survival of total knee arthroplasty in hemophilic arthropathy. J Clin Med. 2020;9(10):3247.
  • Mortazavi SJ, Bagheri N, Farhoud A, et al. Total knee arthroplasty in patients with hemophilia: what do we know? Arch Bone Jt Surg. 2020;8:470–478.
  • Pathak N, Munger AM, Charifa A, et al. Total knee arthroplasty in hemophilia A. Arthroplast Today. 2020;6(2):52–58.e1.
  • Oyarzun A, Barrientos C, Barahona M, et al. Knee haemophilic arthropathy care in Chile: midterm outcomes and complications after total knee arthroplasty. Haemophilia. 2020;26(4):e179–e186.
  • Solimeno LP, Pasta G. Knee and ankle arthroplasty in hemophilia. J Clin Med. 2017;6(11):107.
  • Li Z, Feng B, Du Y, et al. Complications of total knee arthroplasty in patients with haemophilia compared with osteoarthritis and rheumatoid arthritis: a 20-year single-surgeon cohort. Haemophilia. 2020;26(5):861–866.
  • Solimeno LP, Mancuso ME, Pasta G, et al. Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs: a review of 116 procedures at a single institution. Br J Haematol. 2009;145(2):227–234.
  • Carulli C, Innocenti M, Linari S, et al. Joint replacement for the management of haemophilic arthropathy in patients with inhibitors: a long-term experience at a single haemophilia centre. Haemophilia. 2021;27(1):93–101.
  • Rosas S, Buller LT, Plate J, et al. Total knee arthroplasty among Medicare beneficiaries with hemophilia A and B is associated with increased complications and higher costs. J Knee Surg. 2021;34(4):372–377.
  • Rodriguez-Merchan EC, Romero-Garrido JA, Gomez-Cardero P. Multimodal blood loss prevention approach including intra-articular tranexamic acid in primary total knee arthroplasty for patients with severe haemophilia A. Haemophilia. 2016;22(4):e318–e320.
  • Badulescu OV, Sirbu PD, Ungureanu C, et al. Orthopedic surgery in hemophilic patients with musculoskeletal disorders: a systematic review. Exp Ther Med. 2021;22(3):995.
  • Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl S6):1–158.
  • McLaughlin P, Aspdahl M, Matlary RED, et al. Comprehensive care on paper only? The challenge for physiotherapy provision in day to day haemophilia practice. Haemophilia. 2021;27(2):e284–e286.
  • De la Corte-Rodriguez H, Rodriguez-Merchan EC, Jimenez-Yuste V. Point-of-care ultrasonography in orthopedic management of hemophilia: multiple uses of an effective tool. HSS J. 2018;14(3):307–313.
  • Seaman CD, Ragni MV. Emicizumab use in major orthopedic surgery. Blood Adv. 2019;3(11):1722–1724.
  • Jimenez-Yuste V, Rodriguez-Merchan EC, Matsushita T, et al. Concomitant use of bypassing agents with emicizumab for people with haemophilia A and inhibitors undergoing surgery. Haemophilia. 2021;00:1–12.
  • Escuriola-Ettingshausen C, Auerswald G, Königs C, et al. Optimizing the management of patients with haemophilia A and inhibitors in the era of emicizumab: recommendations from a German expert panel. Haemophilia. 2021;27(3):e305–e313.
  • Shapiro AD. Concizumab: a novel anti-TFPI therapeutic for hemophilia. Blood Adv. 2021;5(1):279.
  • Pasi KJ, Lissitchkov T, Mamonov V, et al. Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort. J Thromb Haemost. 2021;19(6):1436–1446.
  • Osooli M, Donfield SM, Carlsson KS, et al. Joint comorbidities among Swedish carriers of haemophilia: a register-based cohort study over 22 years. Haemophilia. 2019;25(5):845–850.
  • Valentino LA, Skinner MW, Pipe SW. The role of telemedicine in the delivery of health care in the COVID-19 pandemic. Haemophilia. 2020;26:e230–e231.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.